Skip to main content

Technological Innovation

Following a customer-centric approach, the main objective of VIVEbiotech’s Custom Solution & Process Development Department is to develop the most productive, functional and regulatory-compliant vector before the production phase in bioreactors, whether for ex-vivo and in-vivo administration.
Tecnología i+d

Improve producer cell lines, including the possibility of genetic modification to:

  • Enhance productivity.
  • Increase tropism.
  • Optimize expansion.
  • Obtain a stable cell line.

Develop new analytical methods to:

  • Better understand our process and/or product.
  • Improve analytical methods for batch release.
  • Custom development of potency assays.

Different pseudotyping strategies.

Optimizing conditions to maximize yields.

Purification process optimization for peak performance.


Other areas of innovation:

  • Development of integrative and non-integrative vector systems.
  • Engineering and delivery of large trangenes.
  • Design and optimization across multiple lentiviral vector generations.

+ 10 in-vivo lentiviral vector programs, several in clinical development.

GMP-certified for clinical-grade release.